| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8452949 | Hematology/Oncology and Stem Cell Therapy | 2017 | 21 Pages |
Abstract
Fever after peripheral blood stem cell infusion in this clinical setting was common; it usually subsides with cyclophosphamide administration. The development of fever was not associated with an adverse prognosis.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marcos Arango, Juan F. Combariza,